StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 
 
 
Vaxcyte
76.87
+4.06%
 

PCVX

 

Vaxcyte

$ 76.87

 
+$3.00 | +4.06%
 
 
Open
$ 74.45
 
 
MKT CAP
$ 8.15B
 
High
$ 77.69
 
 
VOL
$ 1.03M
 
Low
$ 74.28
 
 
AVG VOL
$ 0.98M
 
 
 

PCVX Stock Analysis

  Login to display Vaxcyte (PCVX) recommendation from the last 90 days from financial news and social media.
 
 

PCVX Total Score

 

Chart

 
 

60

49.33

45.35

41.67

 
 
1month
3month
6month
1year
 
Total Return
PCVX
vs.
S&P500
 

 
1-week Return
+2.48%
 
+1.17%
 
 
5-week Return
+26.35%
 
+6.44%
 
 
10-week Return
+32.92%
 
+10.09%
 
 
 
 

Strengths

PCVX Rewards

 Insider buying over the past 3 months

 

Risk Analysis

PCVX Risk Analysis

 Downgraded on weak valued

 
 

PCVX Risk Level

This Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
PCVX Risk Level
LOW
HIGH

Risk Volatility

 

PCVX has Low Risk Level

Click here to check what is your level of risk

 

PCVX Analysts Opinion

The company overall standing based on key factors, offering insights into analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

4.00
 

PCVX Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

2.00
 

PCVX Rating Sentiment

 Downgraded on weak valued

 

Momentum

×
 

Momentum

2.00
 

PCVX Momentum Analysis

 Price value has negative momentum

 

Activity

×
 

Activity

3.00
 

PCVX Activity Sentiment

 Insider buying over the past 3 months

 

Future

×
 

Future

3.00
 
 
 

PCVX Analysts Opinion

PCVX Analysts opinion is negative but has improved from the past 3 months

 

PCVX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
40%
Buy
Opinion
Trend
Score
Potential
Score
 
 
0%
0%
0%
 
On Track
On Track
On Track
 

PCVX Street Opinion 

PCVX Street view is unimpressive and have negative views on the near-term outlook

 

PCVX Performance Sentiment

Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
40%
40%
Positive
Negative
4 out of 10
events present
4 out of 10
events present
 
 
Highlights
Last Modify
Price
% Change

 
Investors Activity
3 Weeks Ago
75.53
+5.75%
 
Insider Buying
3 Weeks Ago
71.42
+6.04%
 
Strong Earnings
3 Weeks Ago
67.35
-1.68%
 
 

PCVX Latest News Feed






Thu Dec 28, 2023

Potential

 
 
 
joker
 
 
 
StocksRunner

Explore our PCVX Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our PCVX Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 

Most Trending

 
 

-2.76%

 
 
 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

PCVX Rewards

 Insider buying over the past 3 months

 

Risk Analysis

 

PCVX Risk Analysis

 Downgraded on weak valued

 
 
 

PCVX Risk Level

 
 
 

The Indicator assigning risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
PCVX Risk Level
LOW
HIGH

Risk Volatility

 

PCVX has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

PCVX

 

Vaxcyte

$ 76.87

 
+$3.00 | +4.06%
 
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 74.45
 
 
MKT CAP
$ 8.15B
 
High
$ 77.69
 
 
VOL
$ 1.03M
 
Low
$ 74.28
 
 
AVG VOL
$ 0.98M
 
 
 

PCVX Analysis

  Sign in to view Vaxcyte (PCVX) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

60

49.33

45.35

41.67

 
 
1month
3month
6month
1year
 
Total Return
PCVX
vs.
S&P500
 

 
1-week Return
+2.48%
 
+1.17%
 
 
5-week Return
+26.35%
 
+6.44%
 
 
10-week Return
+32.92%
 
+10.09%
 
 
 

PCVX Analysts Opinion

Overall standing by considering key factors, reflecting analysts perspectives and market expectations. Hover over the category for more information

 
 

Earnings

×
 

Earnings

4.00
 

PCVX Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

2.00
 

PCVX Rating Sentiment

 Downgraded on weak valued

 

Momentum

×
 

Momentum

2.00
 

PCVX Momentum Sentiment

 Price value has negative momentum

 

Activity

×
 

Activity

3.00
 

PCVX Activity Sentiment

 Insider buying over the past 3 months

 

Future

×
 

Future

3.00
 
 
 

PCVX Analysts Opinion

PCVX Analysts opinion is negative but has improved from the past 3 months

 

PCVX Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
40%
Buy
Opinion
Trend
Score
Potential
Score
 
 
0%
0%
0%
 
On Track
On Track
On Track
 

PCVX Street Opinion 

PCVX Street view is unimpressive and have negative views on the near-term outlook

 
PCVX Performance Sentiment
Sentiments overview associated with the company events and the stock performance.
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
Contrasts the positive and negative sentiments surrounding the company performance.
 
40%
40%
Positive
Negative
4 out of 10
events present
4 out of 10
events present
 

 
Highlights
Last Modify
Price
% Change

 
Investors Activity
3 Weeks Ago
75.53
+5.75%
 
Insider Buying
3 Weeks Ago
71.42
+6.04%
 
Strong Earnings
3 Weeks Ago
67.35
-1.68%
 
 
PCVX Latest News Feed

vaxcyte to present at the guggenheim healthcare talks | 6th annual biotechnology conference. san carlos calif. feb. 01 2024 (globe newswire) -- vaxcyte inc. (nasdaq: pcvx) a clinical-stage vaccine innovation company engineering high-fidelity vaccines to

Thu Feb 1, 2024

Activity

vaxcyte prices public offering of common shares and warrants. (rttnews) - vaxcyte inc. (pcvx) a clinical-stage vaccine company wednesday announced the pricing of its public offering of 10.93 million common shares and pre-funded warrants to purch

Wed Jan 31, 2024

Activity
Activity
Activity

pcvx crosses above average analyst target. in recent trading shares of vaxcyte inc (symbol: pcvx) have crossed above the average analyst 12-month target price of $66.86 changing hands for $68.52/share. when a stock reaches the target an analyst

Tue Jan 30, 2024

Earnings
Potential
Rating

vaxcyte slips after pipeline updates.

Fri Jan 5, 2024

Momentum

vaxcyte: looking fully valued.

Thu Dec 28, 2023

Potential

 
 
 
 
 

Score Tracker

 
 
 
Based on 10 events in the last 90 days from financial news and social media. Last updated Feb 23, 2024 13:28 Wall St. time
 
 

PCVX Total Score

 
 
 
 
 
 
 
StocksRunner

Discover PCVX Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of PCVX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our PCVX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

PCVX Stock trends

PCVX Stock performance

PCVX Stock analysis

PCVX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker